查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1787968

全球獸醫治療市場預測（至 2032 年）：按產品、動物類型、給藥途徑、通路和地區分類

Veterinary therapeutics Market Forecasts to 2032 - Global Analysis By Product (Veterinary Drugs, Veterinary Vaccines and Medicated Feed Additives), Animal Type, Route of Administration, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球獸醫治療市場預計在 2025 年達到 588 億美元，到 2032 年將達到 1,102 億美元，預測期內的複合年成長率為 9.4%。

獸醫學是獸醫學的一個分支學科，專注於運用藥理學、免疫學和支持性護理對動物疾病進行診斷、治療和管理。獸醫學涵蓋多種介入措施，包括針對不同動物種類的抗生素、疫苗、抗寄生蟲藥物、止痛藥和生物製藥。這些治療策略旨在恢復動物健康、緩解疼痛、預防疾病進展並改善動物整體福祉。獸醫學在畜牧生產力、通用感染疾病控制和公共衛生方面也發揮著重要作用。

根據世界動物衛生組織統計，口蹄疫影響全球77.0%的牲畜。

寵物飼養的興起以及人與動物之間的聯繫

寵物擁有量的激增以及人與動物之間日益加深的聯繫，大大推動了獸醫護理市場的發展。隨著寵物日益被視為家庭成員，人們對先進的個人化照護的需求也日益成長，包括慢性疾病的預防和治療。這種情感連結推動了人們在健康、創新治療方法和診斷方面的支出增加。此外，人們對寵物健康的日益關注也推動了獸醫醫療服務的產品開發和擴展，從而增強了市場在製藥、生技藥品和伴侶動物護理領域的強勁成長和創新軌跡。

高級獸醫護理高成本

先進獸醫治療的高昂成本是市場成長的一大障礙，尤其是在寵物保險有限且負擔能力堪憂的新興市場。如此高昂的費用往往會阻礙寵物飼主和畜牧養殖戶及時尋求治療，導致寵物擁有率下降。經濟負擔也阻礙了小型診所提供創新治療方法，最終阻礙了市場擴張和獲得尖端獸醫解決方案的管道。

獸醫學技術進步

獸醫技術的進步正在透過提高診斷準確性、療效和個人化治療來改變獸醫護理市場。人工智慧診斷、遠端醫療和再生療法等創新正在加速早期疾病的檢測並改善治療效果。智慧型設備與資料分析的融合正在促進即時監控和決策。這些發展不僅提高了臨床效率並降低了成本，還擴大了醫療保健的可近性，推動了市場成長並促進了獸醫護理的持續創新。

嚴格的監管核准

嚴格的監管核准對獸藥市場構成了重大障礙。冗長的核准流程、複雜的文件以及嚴格的安全性和有效性測試，不僅延誤了產品的上市，還增加了開發成本。規模較小的公司往往難以滿足這些要求，從而限制了創新和市場准入。雖然這些嚴格的法規對動物福利至關重要，但它們卻構成了瓶頸，限制了快速發展和跨地區新型治療方法的可近性。

COVID-19的影響

新冠疫情對獸醫治療市場產生了許多影響。最初，封鎖和旅行限制擾亂了獸醫服務和供應鏈，導致非緊急治療延誤。然而，這場危機也提高了人們對通用感染疾病的認知，並凸顯了建立健全動物衛生系統的重要性。在疫情封鎖期間，寵物擁有量激增，推動了伴侶動物藥物的需求。隨著全球適應疫情，遠端醫療和居家照護解決方案日益受到青睞，重塑了動物照護的交付模式。

獸用疫苗市場預計將成為預測期內最大的市場

獸用疫苗領域預計將在預測期內佔據最大的市場佔有率，因為其預防特性可以降低治療成本並支持永續的動物健康管理。疫苗開發技術的進步，例如重組疫苗和基於載體的平台，正在推動各種治療方法的創新。此外，疫苗還有助於遏制通用感染疾病的傳播並確保更安全的食品供應，從而促進公共衛生。這一成長領域不僅補充了治療性介入，而且還透過改善疾病控制來加速市場擴張。

預計網路商店部分在預測期內將實現最高的複合年成長率。

預計網路商店細分市場將在預測期內實現最高成長率，因為這些平台簡化了寵物飼主和牲畜飼養者的產品發現流程，透過具有競爭力的價格提高了可負擔性，並增強了偏遠地區的市場滲透率。此外，電子商務促進了直接面對消費者的配送，提高了便利性並促進了獸醫護理方案的依從性。與人工智慧驅動的建議和訂閱模式的整合將進一步最佳化治療效果，推動市場持續成長。

佔比最大的地區：

由於寵物擁有量不斷成長以及人們對動物健康的意識不斷增強，預計亞太地區將在預測期內佔據最大的市場佔有率。印度、中國和韓國等國家正在投資先進的治療和預防性醫療保健，推動對疫苗、診斷和藥物的需求。技術創新和政府措施正在加強獸醫基礎設施建設，改善疾病控制，並支持糧食安全。這個充滿活力的市場正在推動全部區域的經濟發展，並提高動物福利標準。

複合年成長率最高的地區：

由於伴侶動物醫療保健支出高昂且獸醫基礎設施先進，北美預計將在預測期內實現最高的複合年成長率。該地區受益於強大的獸醫診所網路、廣泛的保險覆蓋以及生物製藥和精準診斷等創新療法的早期採用。政府的支持性法規和日益增強的通用感染疾病預防意識將進一步提振市場。北美技術先進的生態系統和對動物福利的重視將繼續推動對有效治療方案的需求。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球獸醫治療市場（按產品）

  • 獸藥
    • 抗感染藥物
    • 抗發炎藥物
    • 殺蟲劑
  • 獸用疫苗
    • 惰性
    • 減毒活疫苗
    • 重組
  • 藥用飼料添加劑
    • 抗生素
    • 球蟲藥物
    • 驅蟲藥

6. 全球獸醫治療市場（依動物類型）

  • 伴侶動物
    • 狗
    • 馬
    • 貓
  • 家畜
    • 牛
    • 綿羊/山羊
    • 家禽
    • 豬

7. 全球獸醫治療市場（依給藥途徑）

  • 口服
  • 腸外
  • 局部的
  • 氣霧劑

8. 全球獸醫治療市場（依通路）

  • 獸醫醫院和診所
  • 飼料店
  • 藥局
  • 網路商店
  • 其他

9. 全球獸醫治療市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要發展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章：公司簡介

  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol SA
  • Dechra Pharmaceuticals PLC
  • IDEXX Laboratories, Inc.
  • Phibro Animal Health Corporation
  • Norbrook Laboratories Ltd.
  • Zydus Animal Health
  • Kindred Biosciences, Inc.
  • Neogen Corporation
  • Bimeda Animal Health
  • Biogenesis Bago
  • Ourofino Saude Animal
  • Kyoritsu Seiyaku Corporation
Product Code: SMRC30233

According to Stratistics MRC, the Global Veterinary Therapeutics Market is accounted for $58.8 billion in 2025 and is expected to reach $110.2 billion by 2032 growing at a CAGR of 9.4% during the forecast period. Veterinary therapeutics refers to the branch of veterinary medicine that focuses on diagnosing, treating, and managing animal diseases using pharmacological, immunological, and supportive therapies. It encompasses a wide range of interventions, including antibiotics, vaccines, antiparasitics, analgesics, and biologics tailored to various species. These therapeutic strategies aim to restore health, alleviate pain, prevent disease progression, and improve overall animal welfare. Veterinary therapeutics also plays a vital role in livestock productivity, zoonotic disease control, and public health.

According to the World Organization for Animal Health, foot and mouth disease affects 77.0% of the global livestock population.

Market Dynamics:

Driver:

Rising Pet Ownership & Human-Animal Bond

The surge in pet ownership and deepening human-animal bonds is significantly propelling the Veterinary therapeutics market. With pets increasingly seen as family, there's rising demand for advanced, personalized care, including preventive and chronic condition treatments. This emotional connection drives higher spending on wellness, innovative therapies, and diagnostics. Moreover, growing awareness of pet health fosters product development and veterinary service expansion, reinforcing the market's trajectory toward robust growth and innovation across pharmaceuticals, biologics, and companion animal care segments.

Restraint:

High Cost of Advanced Veterinary therapeutics

The high cost of advanced Veterinary therapeutics poses a significant barrier to market growth, especially in developing regions where pet insurance is limited and affordability is a concern. These costly treatments often deter pet owners and livestock farmers from seeking timely care, leading to reduced adoption rates. The financial burden also discourages smaller clinics from stocking innovative therapies, ultimately hindering market expansion and access to cutting-edge veterinary solutions.

Opportunity:

Technological Advancements in Veterinary Medicine

Technological advancements in veterinary medicine are transforming the Veterinary therapeutics market by enhancing diagnostic precision, treatment efficacy, and personalized care. Innovations such as AI-driven diagnostics, telemedicine, and regenerative therapies are accelerating early disease detection and improving outcomes. The integration of smart devices and data analytics boosts real-time monitoring and decision-making. These developments not only increase clinical efficiency and reduce costs but also expand access to care, driving market growth and fostering continuous innovation in Veterinary therapeutics.

Threat:

Stringent Regulatory Approvals

Stringent regulatory approvals pose a significant hindrance to the Veterinary therapeutics market. Lengthy approval timelines, complex documentation, and rigorous safety and efficacy trials delay product launches and increase development costs. Smaller players often struggle to meet these demands, limiting innovation and market entry. These strict regulations, though essential for animal welfare, act as a bottleneck, restricting swift advancements and the availability of novel therapies across regions.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the Veterinary therapeutics market. Initially, lockdowns and movement restrictions disrupted veterinary services, supply chains, and delayed non-urgent treatments. However, the crisis also heightened awareness of zoonotic diseases, emphasizing the need for robust animal health systems. Pet adoption surged during lockdowns, increasing demand for companion animal therapeutics. As the world adapted, telemedicine and home-care solutions gained traction, reshaping veterinary care delivery models.

The veterinary vaccines segment is expected to be the largest during the forecast period

The veterinary vaccines segment is expected to account for the largest market share during the forecast period because their preventive nature lowers treatment costs and supports sustainable animal health management. Technological advancements in vaccine development-such as recombinant and vector-based platforms-drive innovation across therapeutics. Additionally, vaccines contribute to public health by curbing zoonotic transmissions and ensuring safer food supplies. This growing segment not only complements therapeutic interventions but also accelerates market expansion through improved disease control.

The online stores segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the online stores segment is predicted to witness the highest growth rate as these platforms streamline product discovery for pet owners and livestock managers, improve affordability through competitive pricing, and enhance market penetration in remote areas. Additionally, e-commerce facilitates direct-to-consumer delivery, fostering convenience and compliance with veterinary care regimens. Their integration with AI-powered recommendations and subscription models is further optimizing therapeutic outcomes and driving sustained market growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising pet ownership and heightened awareness of animal health. Countries like India, China, and South Korea are investing in advanced treatments and preventive care, boosting demand for vaccines, diagnostics, and pharmaceuticals. Technological innovations and government initiatives are enhancing veterinary infrastructure, improving disease management, and supporting food security. This dynamic market is fostering economic development and elevating standards in animal welfare across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to high spending on companion animal healthcare, and advanced veterinary infrastructure. The region benefits from a strong network of veterinary clinics, widespread insurance coverage, and early adoption of innovative treatments like biologics and precision diagnostics. Supportive government regulations and growing awareness about zoonotic disease control further boost the market. North America's technologically advanced ecosystem and emphasis on animal welfare continue to drive the demand for effective therapeutic solutions.

Key players in the market

Some of the key players profiled in the Veterinary therapeutics Market include Zoetis Inc., Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Zydus Animal Health, Kindred Biosciences, Inc., Neogen Corporation, Bimeda Animal Health, Biogenesis Bago, Ourofino Saude Animal and Kyoritsu Seiyaku Corporation.

Key Developments:

In June 2025, Infosys has entered into a strategic, long-term consulting partnership with Zoetis, the world's leading animal health company, Under this deal, Infosys will support Zoetis by integrating advanced AI driven solutions, automation, and digital enhancements into their IT operations. The goal is to boost agility and streamline systems, enabling Zoetis to better serve veterinarians, livestock producers, and pet owners globally.

In April 2025, Elanco has entered into a strategic research partnership with WEDterinary LLC, to pursue groundbreaking therapies for chronic kidney disease (CKD) in cats and explore approaches for extending healthy lifespan in pets. The first phase of this collaboration involves pioneering targeted gene therapy specifically aimed at treating feline CKD, while also delving into emerging technologies in life-extension for companion animals.

Products Covered:

  • Veterinary Drugs
  • Veterinary Vaccines
  • Medicated Feed Additives

Animal Types Covered:

  • Companion Animals
  • Livestock Animals

Routes of Administration Covered:

  • Oral
  • Parenteral
  • Topical
  • Aerosol

Distribution Channels Covered:

  • Veterinary Hospitals & Clinics
  • Feed Stores
  • Pharmacies
  • Online Stores
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Veterinary therapeutics Market, By Product

  • 5.1 Introduction
  • 5.2 Veterinary Drugs
    • 5.2.1 Anti-infectives
    • 5.2.2 Anti-inflammatory
    • 5.2.3 Parasiticides
  • 5.3 Veterinary Vaccines
    • 5.3.1 Inactivated
    • 5.3.2 Live Attenuated
    • 5.3.3 Recombinant
  • 5.4 Medicated Feed Additives
    • 5.4.1 Antimicrobials
    • 5.4.2 Anticoccidials
    • 5.4.3 Antiparasitics

6 Global Veterinary therapeutics Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Companion Animals
    • 6.2.1 Dogs
    • 6.2.2 Horses
    • 6.2.3 Cats
  • 6.3 Livestock Animals
    • 6.3.1 Cattle
    • 6.3.2 Sheep & Goats
    • 6.3.3 Poultry
    • 6.3.4 Swine

7 Global Veterinary therapeutics Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Topical
  • 7.5 Aerosol

8 Global Veterinary therapeutics Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Veterinary Hospitals & Clinics
  • 8.3 Feed Stores
  • 8.4 Pharmacies
  • 8.5 Online Stores
  • 8.6 Other Distribution Channels

9 Global Veterinary therapeutics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Zoetis Inc.
  • 11.2 Elanco Animal Health Incorporated
  • 11.3 Merck Animal Health
  • 11.4 Boehringer Ingelheim Animal Health
  • 11.5 Ceva Sante Animale
  • 11.6 Virbac
  • 11.7 Vetoquinol S.A.
  • 11.8 Dechra Pharmaceuticals PLC
  • 11.9 IDEXX Laboratories, Inc.
  • 11.10 Phibro Animal Health Corporation
  • 11.11 Norbrook Laboratories Ltd.
  • 11.12 Zydus Animal Health
  • 11.13 Kindred Biosciences, Inc.
  • 11.14 Neogen Corporation
  • 11.15 Bimeda Animal Health
  • 11.16 Biogenesis Bago
  • 11.17 Ourofino Saude Animal
  • 11.18 Kyoritsu Seiyaku Corporation

List of Tables

  • 1 Global Veterinary therapeutics Market Outlook, By Region (2024-2032) ($MN)
  • 2 Global Veterinary therapeutics Market Outlook, By Product (2024-2032) ($MN)
  • 3 Global Veterinary therapeutics Market Outlook, By Veterinary Drugs (2024-2032) ($MN)
  • 4 Global Veterinary therapeutics Market Outlook, By Anti-infectives (2024-2032) ($MN)
  • 5 Global Veterinary therapeutics Market Outlook, By Anti-inflammatory (2024-2032) ($MN)
  • 6 Global Veterinary therapeutics Market Outlook, By Parasiticides (2024-2032) ($MN)
  • 7 Global Veterinary therapeutics Market Outlook, By Veterinary Vaccines (2024-2032) ($MN)
  • 8 Global Veterinary therapeutics Market Outlook, By Inactivated (2024-2032) ($MN)
  • 9 Global Veterinary therapeutics Market Outlook, By Live Attenuated (2024-2032) ($MN)
  • 10 Global Veterinary therapeutics Market Outlook, By Recombinant (2024-2032) ($MN)
  • 11 Global Veterinary therapeutics Market Outlook, By Medicated Feed Additives (2024-2032) ($MN)
  • 12 Global Veterinary therapeutics Market Outlook, By Antimicrobials (2024-2032) ($MN)
  • 13 Global Veterinary therapeutics Market Outlook, By Anticoccidials (2024-2032) ($MN)
  • 14 Global Veterinary therapeutics Market Outlook, By Antiparasitics (2024-2032) ($MN)
  • 15 Global Veterinary therapeutics Market Outlook, By Animal Type (2024-2032) ($MN)
  • 16 Global Veterinary therapeutics Market Outlook, By Companion Animals (2024-2032) ($MN)
  • 17 Global Veterinary therapeutics Market Outlook, By Dogs (2024-2032) ($MN)
  • 18 Global Veterinary therapeutics Market Outlook, By Horses (2024-2032) ($MN)
  • 19 Global Veterinary therapeutics Market Outlook, By Cats (2024-2032) ($MN)
  • 20 Global Veterinary therapeutics Market Outlook, By Livestock Animals (2024-2032) ($MN)
  • 21 Global Veterinary therapeutics Market Outlook, By Cattle (2024-2032) ($MN)
  • 22 Global Veterinary therapeutics Market Outlook, By Sheep & Goats (2024-2032) ($MN)
  • 23 Global Veterinary therapeutics Market Outlook, By Poultry (2024-2032) ($MN)
  • 24 Global Veterinary therapeutics Market Outlook, By Swine (2024-2032) ($MN)
  • 25 Global Veterinary therapeutics Market Outlook, By Route of Administration (2024-2032) ($MN)
  • 26 Global Veterinary therapeutics Market Outlook, By Oral (2024-2032) ($MN)
  • 27 Global Veterinary therapeutics Market Outlook, By Parenteral (2024-2032) ($MN)
  • 28 Global Veterinary therapeutics Market Outlook, By Topical (2024-2032) ($MN)
  • 29 Global Veterinary therapeutics Market Outlook, By Aerosol (2024-2032) ($MN)
  • 30 Global Veterinary therapeutics Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • 31 Global Veterinary therapeutics Market Outlook, By Veterinary Hospitals & Clinics (2024-2032) ($MN)
  • 32 Global Veterinary therapeutics Market Outlook, By Feed Stores (2024-2032) ($MN)
  • 33 Global Veterinary therapeutics Market Outlook, By Pharmacies (2024-2032) ($MN)
  • 34 Global Veterinary therapeutics Market Outlook, By Online Stores (2024-2032) ($MN)
  • 35 Global Veterinary therapeutics Market Outlook, By Other Distribution Channels (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.